$CBUS
Cibus, Inc.

2022 Q3 Form 10-Q Financial Statement

#000119312522212583 Filed on August 04, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $42.00K $41.00K $32.00K
YoY Change -99.46% -99.65% -99.27%
Cost Of Revenue $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
Gross Profit $42.00K $41.00K $32.00K
YoY Change -108.09% -88.39% -101.37%
Gross Profit Margin 100.0% 100.0% 100.0%
Selling, General & Admin $3.229M $3.556M $3.180M
YoY Change -16.33% 1.8% -25.87%
% of Gross Profit 7688.1% 8673.17% 9937.5%
Research & Development $3.016M $3.250M $2.941M
YoY Change 16.94% 14.28% -3.57%
% of Gross Profit 7180.95% 7926.83% 9190.63%
Depreciation & Amortization $395.0K $393.0K $370.0K
YoY Change -33.72% -33.39% -36.75%
% of Gross Profit 940.48% 958.54% 1156.25%
Operating Expenses $6.245M $6.806M $6.121M
YoY Change -3.0% 7.4% -16.58%
Operating Profit -$6.203M -$6.765M -$6.089M
YoY Change -10.84% 13.05% -37.1%
Interest Expense $57.00K $6.000K $470.0K
YoY Change -83.99% -98.33% 30.56%
% of Operating Profit
Other Income/Expense, Net $300.0K $4.296M $487.0K
YoY Change 4900.0% 71500.0% -48800.0%
Pretax Income -$5.950M -$2.485M -$5.619M
YoY Change -18.57% -48.3% -43.97%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$5.950M -$2.485M -$5.619M
YoY Change -18.57% -48.3% -43.97%
Net Earnings / Revenue -14166.67% -6060.98% -17559.38%
Basic Earnings Per Share -$0.13 -$0.05 -$1.34
Diluted Earnings Per Share -$0.13 -$0.05 -$133.7K
COMMON SHARES
Basic Shares Outstanding 46.79M 46.66M 42.72M
Diluted Shares Outstanding 46.78M 46.66M 4.202M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $7.031M $11.32M $17.29M
YoY Change -49.5% -35.3% -10.9%
Cash & Equivalents $7.031M $11.32M $17.29M
Short-Term Investments
Other Short-Term Assets $913.0K $1.547M $1.688M
YoY Change -37.03% 51.37% -54.38%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $7.944M $12.86M $18.97M
YoY Change -53.95% -48.49% -34.8%
LONG-TERM ASSETS
Property, Plant & Equipment $4.859M $5.077M $19.10M
YoY Change -77.37% -76.92% -15.12%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $163.0K $169.0K $274.0K
YoY Change -16.41% -18.36% -65.75%
Total Long-Term Assets $18.76M $19.15M $19.37M
YoY Change -15.77% -16.0% -16.86%
TOTAL ASSETS
Total Short-Term Assets $7.944M $12.86M $18.97M
Total Long-Term Assets $18.76M $19.15M $19.37M
Total Assets $26.70M $32.02M $38.35M
YoY Change -32.44% -32.99% -26.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $435.0K $519.0K $1.167M
YoY Change -58.05% -76.23% 16.7%
Accrued Expenses $380.0K $262.0K $2.588M
YoY Change -66.64% -88.74% -46.08%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $120.0K $246.0K $290.0K
YoY Change -68.99% -35.26% -27.5%
Total Short-Term Liabilities $4.200M $4.500M $9.520M
YoY Change -17.65% -37.12% 51.11%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $37.00K $89.00K
YoY Change -99.54%
Other Long-Term Liabilities $80.00K $68.00K $13.82M
YoY Change -91.76% -93.47% 1051.25%
Total Long-Term Liabilities $80.00K $68.00K $13.90M
YoY Change -91.76% -93.47% -32.18%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.200M $4.500M $9.520M
Total Long-Term Liabilities $80.00K $68.00K $13.90M
Total Liabilities $17.86M $18.26M $23.42M
YoY Change -24.64% -29.45% -12.6%
SHAREHOLDERS EQUITY
Retained Earnings -$209.3M -$203.4M
YoY Change 10.75% 11.91%
Common Stock $219.2M $218.2M
YoY Change 6.46% 6.6%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $8.800M $13.76M $14.92M
YoY Change
Total Liabilities & Shareholders Equity $26.70M $32.02M $38.35M
YoY Change -32.44% -32.99% -26.82%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$5.950M -$2.485M -$5.619M
YoY Change -18.57% -48.3% -43.97%
Depreciation, Depletion And Amortization $395.0K $393.0K $370.0K
YoY Change -33.72% -33.39% -36.75%
Cash From Operating Activities -$4.325M -$4.872M -$6.404M
YoY Change 27.02% 166.38% -32.0%
INVESTING ACTIVITIES
Capital Expenditures -$220.0K -$744.0K -$545.0K
YoY Change 218.84% 1910.81% -302.6%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$220.0K -$744.0K -$545.0K
YoY Change 218.84% -124.71% -106.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -164.0K -353.0K 10.41M
YoY Change 76.34% 397.18% 8575.83%
NET CHANGE
Cash From Operating Activities -4.325M -4.872M -6.404M
Cash From Investing Activities -220.0K -744.0K -545.0K
Cash From Financing Activities -164.0K -353.0K 10.41M
Net Change In Cash -4.709M -5.969M 3.462M
YoY Change 32.02% -637.26% -479.19%
FREE CASH FLOW
Cash From Operating Activities -$4.325M -$4.872M -$6.404M
Capital Expenditures -$220.0K -$744.0K -$545.0K
Free Cash Flow -$4.105M -$4.128M -$5.859M
YoY Change 23.05% 130.36% -39.51%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1528000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1180000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
15181000
CY2022Q2 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
53000
CY2021Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
99000
dei Entity Central Index Key
EntityCentralIndexKey
0001705843
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
5077000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
21731000
dei Entity Address State Or Province
EntityAddressStateOrProvince
MN
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-38161
dei Entity Registrant Name
EntityRegistrantName
Calyxt, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
27-1967997
dei Entity Address Address Line1
EntityAddressAddressLine1
2800 Mount Ridge Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Roseville
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
55113-1127
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
859000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
12863000
dei City Area Code
CityAreaCode
651
dei Local Phone Number
LocalPhoneNumber
683-2807
dei Security12b Title
Security12bTitle
Common Stock (0.0001 par value)
dei Trading Symbol
TradingSymbol
CLXT
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
46792093
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11316000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13823000
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
545000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
499000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1002000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
13855000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
0
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
169000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
183000
CY2022Q2 us-gaap Assets
Assets
32017000
CY2021Q4 us-gaap Assets
Assets
37194000
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
519000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1260000
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
262000
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
339000
CY2022Q2 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2272000
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2522000
CY2022Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
101000
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
172000
CY2022Q2 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
246000
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
370000
CY2022Q2 clxt Common Stock Warrants Current
CommonStockWarrantsCurrent
688000
CY2021Q4 clxt Common Stock Warrants Current
CommonStockWarrantsCurrent
0
CY2022Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
413000
CY2021Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
191000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4501000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4854000
CY2022Q2 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
37000
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
218161000
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
211263000
CY2022Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100152
CY2021Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
100152
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
17506000
CY2022Q2 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
13652000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0
us-gaap Operating Expenses
OperatingExpenses
12927000
CY2021Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
1043000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-203364000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
6806000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
6337000
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
68000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
702000
CY2022Q2 us-gaap Liabilities
Liabilities
18258000
CY2021Q4 us-gaap Liabilities
Liabilities
23062000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
275000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
46815694
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
46715542
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
38874146
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38773994
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
5000
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
4000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-196092000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
13759000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14132000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
32017000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
37194000
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
41000
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11880000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
73000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16282000
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
11527000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
18272000
CY2022Q2 us-gaap Gross Profit
GrossProfit
41000
CY2021Q2 us-gaap Gross Profit
GrossProfit
353000
us-gaap Gross Profit
GrossProfit
73000
us-gaap Gross Profit
GrossProfit
-1990000
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3250000
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2844000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6191000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5894000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3556000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3493000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6736000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7781000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-14835000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Operating Expenses
OperatingExpenses
13675000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-6765000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-5984000
us-gaap Operating Income Loss
OperatingIncomeLoss
-12854000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Operating Income Loss
OperatingIncomeLoss
-15665000
CY2022Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2021Q2 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1528000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2485000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
13759000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
25605000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4807000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1079000
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-16000
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-357000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-33000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-703000
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4296000
CY2021Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
4783000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
5000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2485000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4807000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8104000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-4807000
us-gaap Net Income Loss
NetIncomeLoss
-8104000
us-gaap Net Income Loss
NetIncomeLoss
-14835000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.05
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.13
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.18
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.18
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.4
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.4
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
46663475
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46663475
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37199349
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37199349
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44354610
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44354610
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
37168018
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
37168018
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16234030
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5223327
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
16234030
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
5223327
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
14921000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-2485000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1323000
us-gaap Profit Loss
ProfitLoss
-14835000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
1528000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
21896000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
14132000
us-gaap Net Income Loss
NetIncomeLoss
-8104000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1855000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
763000
clxt Cumulative Effect Of Adoption Of Lease Accounting Standard
CumulativeEffectOfAdoptionOfLeaseAccountingStandard
832000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
13759000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
36875000
us-gaap Net Income Loss
NetIncomeLoss
-14835000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
-371000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
21896000
us-gaap Profit Loss
ProfitLoss
-8104000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-250000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
143000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
550000
us-gaap Share Based Compensation
ShareBasedCompensation
1855000
us-gaap Share Based Compensation
ShareBasedCompensation
-371000
clxt Unrealized Gain Loss On Marktomarket Of Common Stock Warrants
UnrealizedGainLossOnMarktomarketOfCommonStockWarrants
-4723000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-893000
clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-71000
clxt Increase Decrease In Due To From Related Parties Current
IncreaseDecreaseInDueToFromRelatedPartiesCurrent
-638000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1085000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-5000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-3301000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-114000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1254000
clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-87000
clxt Increase Decrease In Accrued Expenses
IncreaseDecreaseInAccruedExpenses
-555000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-992000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11276000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11249000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
11698000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1289000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
307000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1289000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
11391000
clxt Proceeds From The Issuance Of Common Stock And Pre Funded Warrants
ProceedsFromTheIssuanceOfCommonStockAndPreFundedWarrants
11209000
clxt Payments Of Stock And Warrants Issuance Costs
PaymentsOfStockAndWarrantsIssuanceCosts
961000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
190000
us-gaap Repayments Of Long Term Capital Lease Obligations
RepaymentsOfLongTermCapitalLeaseObligations
178000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
227000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
10058000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
49000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2507000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
191000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14421000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18289000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11914000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18480000
CY2022Q2 clxt Common Warrants Financing Costs
CommonWarrantsFinancingCosts
-22000
CY2022Q2 clxt Operating And Finance Lease Liabilities Payments Remainder Of Fiscal Year
OperatingAndFinanceLeaseLiabilitiesPaymentsRemainderOfFiscalYear
947000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1446000
us-gaap Net Income Loss
NetIncomeLoss
-8100000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-11300000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
11900000
CY2022Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
500000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
4500000
CY2022Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3880000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000000
CY2022Q1 us-gaap Sale Of Stock Consideration Received On Transaction
SaleOfStockConsiderationReceivedOnTransaction
900000
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
10000000
CY2022Q2 us-gaap Other Liabilities Fair Value Disclosure
OtherLiabilitiesFairValueDisclosure
688000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
38000
CY2022Q2 clxt Operating And Finance Lease Liability Undiscounted Excess Amount
OperatingAndFinanceLeaseLiabilityUndiscountedExcessAmount
11101000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
13955000
CY2022Q2 clxt Estimated Fair Value Of Common Warrants Measurement Input
EstimatedFairValueOfCommonWarrantsMeasurementInput
0.09
CY2021Q4 clxt Finance Lease Obligations Fair Value Disclosure
FinanceLeaseObligationsFairValueDisclosure
14500000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2621614
CY2022Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
283000
CY2022Q2 clxt Lessee Operating And Finance Lease Liability
LesseeOperatingAndFinanceLeaseLiability
14238000
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2789110
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.23
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
4658405
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.47
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1609000
us-gaap Investment Income Net
InvestmentIncomeNet
16000
CY2021Q2 us-gaap Interest Expense
InterestExpense
359000
us-gaap Interest Expense
InterestExpense
16000
us-gaap Interest Expense
InterestExpense
719000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.12
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
329417
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
7.82
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
3018231
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.2
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5937988
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.3
CY2022Q2 clxt Operating And Finance Lease Liabilities Payments Next Twelve Months
OperatingAndFinanceLeaseLiabilitiesPaymentsNextTwelveMonths
1484000
CY2022Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
CY2021Q2 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
19000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
227000
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
CY2021Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
13000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
344000
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1323000
CY2022Q2 us-gaap Investment Income Net
InvestmentIncomeNet
12000
CY2021Q2 us-gaap Investment Income Net
InvestmentIncomeNet
2000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1480000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
0
us-gaap Lease Cost
LeaseCost
1267000
CY2022Q2 clxt Operating And Finance Lease Liabilities Payments Next Two Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextTwoYears
1480000
CY2022Q2 us-gaap Finance Lease Right Of Use Asset Before Accumulated Amortization
FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
13852000
CY2022Q2 clxt Finance Lease Cost
FinanceLeaseCost
7000
clxt Finance Lease Cost
FinanceLeaseCost
16000
CY2022Q2 us-gaap Operating Lease Cost
OperatingLeaseCost
394000
us-gaap Operating Lease Cost
OperatingLeaseCost
793000
CY2022Q2 us-gaap Variable Lease Cost
VariableLeaseCost
227000
us-gaap Variable Lease Cost
VariableLeaseCost
458000
CY2022Q2 us-gaap Lease Cost
LeaseCost
628000
clxt Payment Of Operating Lease Included In Operating Cash Flow
PaymentOfOperatingLeaseIncludedInOperatingCashFlow
135000
clxt Payment Of Finance Lease Included In Operating Cash Flow
PaymentOfFinanceLeaseIncludedInOperatingCashFlow
0
clxt Payment Of Operating Lease Included In Financing Cash Flow
PaymentOfOperatingLeaseIncludedInFinancingCashFlow
0
clxt Payment Of Finance Lease Included In Financing Cash Flow
PaymentOfFinanceLeaseIncludedInFinancingCashFlow
190000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P15Y9M18D
CY2022Q2 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P0Y6M
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.079
CY2022Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.081
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1079000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1855000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
-371000
CY2022Q2 us-gaap Interest Expense
InterestExpense
6000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
689000
CY2022Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
258000
CY2022Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1479000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
0
CY2022Q2 clxt Operating And Finance Lease Liabilities Payments Next Three Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextThreeYears
1479000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
1479000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
0
CY2022Q2 clxt Operating And Finance Lease Liabilities Payments Next Four Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextFourYears
1479000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
1479000
CY2022Q2 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
0
CY2022Q2 clxt Operating And Finance Lease Liabilities Payments Next Five Years
OperatingAndFinanceLeaseLiabilitiesPaymentsNextFiveYears
1479000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
16991000
CY2022Q2 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
0
CY2022Q2 clxt Operating And Finance Lease Liabilities Payments After Five Years
OperatingAndFinanceLeaseLiabilitiesPaymentsAfterFiveYears
16991000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
25043000
CY2022Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
296000
CY2022Q2 clxt Operating And Finance Lease Liability Payment Due
OperatingAndFinanceLeaseLiabilityPaymentDue
25339000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
11088000
CY2022Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
13000
CY2022Q2 us-gaap Restricted Cash Current
RestrictedCashCurrent
545000
us-gaap Investment Income Net
InvestmentIncomeNet
13000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
11316000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13823000
CY2021Q2 clxt Common Warrants Financing Costs
CommonWarrantsFinancingCosts
0
clxt Common Warrants Financing Costs
CommonWarrantsFinancingCosts
-30000
clxt Common Warrants Financing Costs
CommonWarrantsFinancingCosts
0
CY2022Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-16000
CY2021Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-357000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-33000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-703000
CY2021Q4 us-gaap Restricted Cash Current
RestrictedCashCurrent
499000
CY2022Q2 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
53000
CY2021Q4 us-gaap Restricted Cash Equivalents Noncurrent
RestrictedCashEquivalentsNoncurrent
99000
CY2022Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
11914000
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
14421000
us-gaap Interest Paid
InterestPaid
14000
us-gaap Interest Paid
InterestPaid
716000
clxt Receivable From Jefferies For Shares Issued Under Atm Facility
ReceivableFromJefferiesForSharesIssuedUnderAtmFacility
-260000
clxt Receivable From Jefferies For Shares Issued Under Atm Facility
ReceivableFromJefferiesForSharesIssuedUnderAtmFacility
0
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
618000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
0
clxt Unpaid Stock Offering Costs Included In Stockholders Equity
UnpaidStockOfferingCostsIncludedInStockholdersEquity
1000
clxt Unpaid Stock Offering Costs Included In Stockholders Equity
UnpaidStockOfferingCostsIncludedInStockholdersEquity
0
clxt Cumulative Effect Of Adoption Of Lease Accounting Standard On Stockholders Equity
CumulativeEffectOfAdoptionOfLeaseAccountingStandardOnStockholdersEquity
832000
clxt Cumulative Effect Of Adoption Of Lease Accounting Standard On Stockholders Equity
CumulativeEffectOfAdoptionOfLeaseAccountingStandardOnStockholdersEquity
0
clxt Establishment Of Right To Use Assets And Associated Operating Lease Liabilities.
EstablishmentOfRightToUseAssetsAndAssociatedOperatingLeaseLiabilities.
14090000
clxt Establishment Of Right To Use Assets And Associated Operating Lease Liabilities.
EstablishmentOfRightToUseAssetsAndAssociatedOperatingLeaseLiabilities.
0

Files In Submission

Name View Source Status
0001193125-22-212583-index-headers.html Edgar Link pending
0001193125-22-212583-index.html Edgar Link pending
0001193125-22-212583.txt Edgar Link pending
0001193125-22-212583-xbrl.zip Edgar Link pending
clxt-20220630.xsd Edgar Link pending
clxt-20220630_cal.xml Edgar Link unprocessable
clxt-20220630_def.xml Edgar Link unprocessable
clxt-20220630_lab.xml Edgar Link unprocessable
clxt-20220630_pre.xml Edgar Link unprocessable
d368508d10q.htm Edgar Link pending
d368508d10q_htm.xml Edgar Link completed
d368508dex311.htm Edgar Link pending
d368508dex312.htm Edgar Link pending
d368508dex32.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g368508g0421174450219.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending